236 related articles for article (PubMed ID: 34073890)
1. Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP).
Engdahl E; van Schijndel MDM; Voulgaris D; Di Criscio M; Ramsbottom KA; Rigden DJ; Herland A; Rüegg J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073890
[TBL] [Abstract][Full Text] [Related]
2. The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats.
Nickel S; Mahringer A
Xenobiotica; 2014 Nov; 44(11):1046-54. PubMed ID: 24945792
[TBL] [Abstract][Full Text] [Related]
3. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
[TBL] [Abstract][Full Text] [Related]
4. Structure of the Human Cholesterol Transporter ABCG1.
Skarda L; Kowal J; Locher KP
J Mol Biol; 2021 Oct; 433(21):167218. PubMed ID: 34461069
[TBL] [Abstract][Full Text] [Related]
5. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
[TBL] [Abstract][Full Text] [Related]
6. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
7. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.
Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A
Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160
[TBL] [Abstract][Full Text] [Related]
8. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
9. Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production.
He H; Buckley M; Britton B; Mu Y; Warner K; Kumar S; Cory TJ
Antivir Chem Chemother; 2018; 26():2040206617745168. PubMed ID: 29343083
[TBL] [Abstract][Full Text] [Related]
10. Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban.
Jacqueroux E; Hodin S; Saib S; He Z; Bin V; Delézay O; Delavenne X
Eur J Pharm Biopharm; 2020 Mar; 148():27-37. PubMed ID: 31945490
[TBL] [Abstract][Full Text] [Related]
11. A Combination of Clioquinol, Zinc and Copper Increases the Abundance and Function of Breast Cancer Resistance Protein in Human Brain Microvascular Endothelial Cells.
Yap C; Short JL; Nicolazzo JA
J Pharm Sci; 2021 Jan; 110(1):338-346. PubMed ID: 32339529
[TBL] [Abstract][Full Text] [Related]
12. Bisphenol A alternatives bisphenol S and bisphenol F interfere with thyroid hormone signaling pathway in vitro and in vivo.
Zhang YF; Ren XM; Li YY; Yao XF; Li CH; Qin ZF; Guo LH
Environ Pollut; 2018 Jun; 237():1072-1079. PubMed ID: 29146198
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.
Miyamoto R; Nozawa T; Shiozuka K; Tabata K
J Pharm Sci; 2019 Mar; 108(3):1085-1089. PubMed ID: 30339864
[TBL] [Abstract][Full Text] [Related]
14. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
[TBL] [Abstract][Full Text] [Related]
15. Parallel assessment of the effects of bisphenol A and several of its analogs on the adult human testis.
Desdoits-Lethimonier C; Lesné L; Gaudriault P; Zalko D; Antignac JP; Deceuninck Y; Platel C; Dejucq-Rainsford N; Mazaud-Guittot S; Jégou B
Hum Reprod; 2017 Jul; 32(7):1465-1473. PubMed ID: 28482050
[TBL] [Abstract][Full Text] [Related]
16. Reduction in ABCG2 mRNA Expression in Human Immortalised Brain Microvascular Endothelial Cells by Ferric Ammonium Citrate is Mediated by Reactive Oxygen Species and Activation of ERK1/2 Signalling.
Newman SA; Short JL; Nicolazzo JA
Pharm Res; 2023 Mar; 40(3):651-660. PubMed ID: 36539667
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicities of BPA, BPS, BPF, and TMBPF in the nematode Caenorhabditis elegans and mammalian fibroblast cells.
Hyun M; Rathor L; Kim HJ; McElroy T; Hwang KH; Wohlgemuth S; Curry S; Xiao R; Leeuwenburgh C; Heo JD; Han SM
Toxicology; 2021 Sep; 461():152924. PubMed ID: 34474090
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SLC drug transporter activities by environmental bisphenols.
Bruyere A; Hubert C; Le Vee M; Chedik L; Sayyed K; Stieger B; Denizot C; Parmentier Y; Fardel O
Toxicol In Vitro; 2017 Apr; 40():34-44. PubMed ID: 27989701
[TBL] [Abstract][Full Text] [Related]
19. Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability.
Garg P; Dhakne R; Belekar V
Mol Divers; 2015 Feb; 19(1):163-72. PubMed ID: 25502234
[TBL] [Abstract][Full Text] [Related]
20. Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.
Mishra J; Simonsen R; Kumar N
J Biol Chem; 2019 Nov; 294(48):18337-18348. PubMed ID: 31653704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
